Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spinraza
Pharma
With highest quarterly sales since '21, Biogen reverses guidance
Biogen has reversed its 2026 revenue guidance, now expecting a mid-single digit increase versus a previous projection of a mid-single digit decline.
Kevin Dunleavy
Jul 29, 2026 11:05am
Biogen launches ‘Ready for More’ HD Spinraza campaign
Jun 26, 2026 8:17am
Biogen looks to shake up SMA status quo with Spinraza HD nod
Mar 30, 2026 9:58am
Biogen bets HD Spinraza can outmuscle Roche's oral rival
Feb 6, 2026 12:02pm
Biogen undeterred after FDA snub for high-dose Spinraza in SMA
Sep 24, 2025 9:51am
Roche picks up FDA nod for easier Evrysdi dosing format in SMA
Feb 12, 2025 2:30pm
